Cargando…

Healthy Organs Uptake on Baseline (18)F-FDG PET/CT as an Alternative to Total Metabolic Tumor Volume to Predict Event-Free Survival in Classical Hodgkin's Lymphoma

PURPOSE: Healthy organs uptake, including cerebellar and liver SUVs have been reported to be inversely correlated to total metabolic tumor volume (TMTV), a controversial predictor of event-free survival (EFS) in classical Hodgkin's Lymphoma (cHL). The objective of this study was to estimate TMT...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morland, David, Triumbari, Elizabeth Katherine Anna, Maiolo, Elena, Cuccaro, Annarosa, Treglia, Giorgio, Hohaus, Stefan, Annunziata, Salvatore
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256984/ https://www.ncbi.nlm.nih.gov/pubmed/35814740 http://dx.doi.org/10.3389/fmed.2022.913866

Ejemplares similares

Classical Hodgkin Lymphoma: A Joint Clinical and PET Model to Predict Poor Responders at Interim Assessment
por: Triumbari, Elizabeth Katherine Anna, et al.
Publicado: (2022)

Baseline (18)F-FDG PET/CT Radiomics in Classical Hodgkin’s Lymphoma: The Predictive Role of the Largest and the Hottest Lesions
por: Triumbari, Elizabeth Katherine Anna, et al.
Publicado: (2023)

PD‐L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma
por: Cuccaro, Annarosa, et al.
Publicado: (2022)

Prognostic Factors in Hodgkin Lymphoma
por: Cuccaro, Annarosa, et al.
Publicado: (2014)

CD68+ cell count, early evaluation with PET and plasma TARC levels predict response in Hodgkin lymphoma
por: Cuccaro, Annarosa, et al.
Publicado: (2016)

The Role of (18)F-FDG-PET and PET/CT in Patients with Colorectal Liver Metastases Undergoing Selective Internal Radiation Therapy with Yttrium-90: A First Evidence-Based Review
por: Annunziata, Salvatore, et al.
Publicado: (2014)

Clinical Applications of Immuno-PET in Lymphoma: A Systematic Review
por: Triumbari, Elizabeth Katherine Anna, et al.
Publicado: (2022)

Radiomics in Oncological PET Imaging: A Systematic Review—Part 1, Supradiaphragmatic Cancers
por: Morland, David, et al.
Publicado: (2022)

Radiomics in Oncological PET Imaging: A Systematic Review—Part 2, Infradiaphragmatic Cancers, Blood Malignancies, Melanoma and Musculoskeletal Cancers
por: Morland, David, et al.
Publicado: (2022)

(18)F-Fluoroethylcholine PET/CT Radiomic Analysis for Newly Diagnosed Prostate Cancer Patients: A Monocentric Study
por: Pizzuto, Daniele Antonio, et al.
Publicado: (2022)

Severe CMV Infection after Chemo-Immunotherapy with Dose-Reduced Bendamustine and Rituximab in a Mantle Cell Lymphoma Old Patient
por: Magliano, Gabriele, et al.
Publicado: (2021)

Predicting time to treatment in follicular lymphoma on watchful waiting using baseline metabolic tumour burden
por: Leccisotti, Lucia, et al.
Publicado: (2022)

Prevalence and malignancy risk of focal colorectal incidental uptake detected by (18)F-FDG-PET or PET/CT: a meta-analysis
por: Treglia, Giorgio, et al.
Publicado: (2014)

Automated quantification of baseline imaging PET metrics on FDG PET/CT images of pediatric Hodgkin lymphoma patients
por: Weisman, Amy J., et al.
Publicado: (2020)

The role of (18)F-FDG PET for COVID-19 infection: myth versus reality
por: Treglia, Giorgio
Publicado: (2020)

Extracellular vesicle miRNA predict FDG‐PET status in patients with classical Hodgkin Lymphoma
por: Drees, Esther E. E., et al.
Publicado: (2021)

The role of FDG-PET in Hodgkin lymphoma
por: Subocz, Edyta, et al.
Publicado: (2017)

Role of 2-[(18)F]FDG as a Radiopharmaceutical for PET/CT in Patients with COVID-19: A Systematic Review
por: Annunziata, Salvatore, et al.
Publicado: (2020)

(18)F-FDG PET/CT Maximum Tumor Dissemination (Dmax) in Lymphoma: A New Prognostic Factor?
por: Albano, Domenico, et al.
Publicado: (2023)

FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas
por: Barrington, Sally F., et al.
Publicado: (2017)

Venous Thromboembolism in Lymphoma: Risk Stratification and Antithrombotic Prophylaxis
por: Hohaus, Stefan, et al.
Publicado: (2020)

Longitudinal Body Composition Changes Detected by [(18)F]FDG PET/CT during and after Chemotherapy and Their Prognostic Role in Elderly Hodgkin Lymphoma
por: Albano, Domenico, et al.
Publicado: (2022)

Diagnostic Performance of PET Imaging Using Different Radiopharmaceuticals in Prostate Cancer According to Published Meta-Analyses
por: Annunziata, Salvatore, et al.
Publicado: (2020)

Could [(18)F]FDG PET/CT or PET/MRI Be Useful in Patients with Skull Base Osteomyelitis?
por: Dondi, Francesco, et al.
Publicado: (2022)

Diagnostic Performance of (18)F-FDG PET/CT in Infectious and Inflammatory Diseases according to Published Meta-Analyses
por: Treglia, Giorgio
Publicado: (2019)

The Role of 18F-FDG PET/CT in Staging and Prognostication of Mantle Cell Lymphoma: An Italian Multicentric Study
por: Albano, Domenico, et al.
Publicado: (2019)

The “Undetermined Significance” of (18)F-FDG PET/CT or PET/MRI in Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS)
por: Treglia, Giorgio, et al.
Publicado: (2021)

Relationship between Baseline [(18)F]FDG PET/CT Semiquantitative Parameters and BRCA Mutational Status and Their Prognostic Role in Patients with Invasive Ductal Breast Carcinoma
por: Dondi, Francesco, et al.
Publicado: (2022)

Epstein-Barr Virus (EBV)-Associated Haemophagocytic Syndrome
por: Torti, Lorenza, et al.
Publicado: (2012)

Blood‐circulating EV‐miRNAs, serum TARC, and quantitative FDG‐PET features in classical Hodgkin lymphoma
por: Drees, Esther E. E., et al.
Publicado: (2022)

Risk factors for venous thromboembolism in patients with lymphoma requiring hospitalization
por: Hohaus, Stefan, et al.
Publicado: (2018)

Prognostic value of combined MTV and ADC derived from baseline FDG PET/MRI in aggressive non-Hodgkins lymphoma
por: Husby, Trine, et al.
Publicado: (2022)

(18)F-FDG gallbladder uptake: observation from a total-body PET/CT scanner
por: Calabro’, Anna, et al.
Publicado: (2023)

Absolute monocyte count at diagnosis could improve the prognostic role of early FDG‐PET in classical Hodgkin lymphoma patients
por: Bari, Alessia, et al.
Publicado: (2016)

Utility of pre-treatment FDG PET/CT–derived machine learning models for outcome prediction in classical Hodgkin lymphoma
por: Frood, Russell, et al.
Publicado: (2022)

Interleukin-31 and thymic stromal lymphopoietin expression in plasma and lymph node from Hodgkin lymphoma patients
por: Ferretti, Elisa, et al.
Publicado: (2017)

Influence of Software Tool and Methodological Aspects of Total Metabolic Tumor Volume Calculation on Baseline [18F]FDG PET to Predict Survival in Hodgkin Lymphoma
por: Kanoun, Salim, et al.
Publicado: (2015)

On the Added Value of Baseline FDG-PET in Malignant Lymphoma
por: Quarles van Ufford, Henriette, et al.
Publicado: (2009)

Interim FDG-PET Scan in Hodgkin's Lymphoma: Hopes and Caveats
por: André, M., et al.
Publicado: (2011)

Impact of Cold Somatostatin Analog Administration on Somatostatin Receptor Imaging: A Systematic Review
por: Morland, David, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1muj024eu56spik1btbl2rohsg